Cite
HARVARD Citation
Lizak, N. et al. (2017). Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 88 (3), pp. 196-203. [Online].